BioNexus Gene Lab Corp Common stock (BGLC) had the highest return between 2018 and 2022 by a US stock in the Nasdaq Composite (IXIC), returning 2,780,387.8%.

ASSET	YEARS	% RETURN
BioNexus Gene Lab Corp Common stock (BGLC)	2018-2022	2,780,387.8%
Next Technology (NXTT)	2018-2022	1,162,346.87%
Avalon GloboCare (ALBT)	2018-2022	487,400%
Connexa Sports Technologies (YYAI)	2018-2022	467,900%
GeoVax Labs (GOVX)	2018-2022	363,361.54%
Heart Test Laboratories Inc Common Stock (HSCS)	2018-2022	246,958.82%
Immatics (IMTX)	2018-2022	174,100%
MDxHealth SA ADR (MDXH)	2018-2022	169,387.18%
INVO Fertility (IVF)	2018-2022	45,126.67%
Applied Digital (APLD)	2018-2022	30,566.67%
FitLife Brands, Inc Common Stock (FTLF)	2018-2022	25,379.23%
Guardforce AI (GFAI)	2018-2022	24,323.08%
Alarum Technologies (ALAR)	2018-2022	19,412.2%
Kaival Brands Innovations (KAVL)	2018-2022	14,858.33%
Bone Biologics (BBLG)	2018-2022	13,199.91%
Enphase Energy (ENPH)	2018-2022	10,986.19%
CIMG (IMG)	2018-2022	8,771.79%
Delcath Systems (DCTH)	2018-2022	6,903.89%
Xpel (XPEL)	2018-2022	4,100%
374Water Inc Common Stock (SCWO)	2018-2022	2,100%
Celsius (CELH)	2018-2022	1,855.68%
Tandem Diabetes Care (TNDM)	2018-2022	1,812.77%
Sigma Lithium Resources (SGML)	2018-2022	1,802.9%
Nocera (NCRA)	2018-2022	1,606.67%
Golden Matrix (GMGI)	2018-2022	1,593.33%